Qube Research & Technologies LTD Exact Sciences Corp Transaction History

Qube Research & Technologies LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$41.33 - $74.26 $17.6 Million - $31.6 Million	-425,597 Reduced 99.99%	34 $1,000
Q1 2024 May 14, 2024	SELL	$56.27 - $73.77 $34.9 Million - $45.8 Million	-620,276 Reduced 59.31%	425,631 $29.4 Million
Q4 2023 Feb 13, 2024	BUY	$59.06 - $75.72 $29.9 Million - $38.3 Million	505,716 Added 93.62%	1,045,907 $77.4 Million
Q3 2023 Nov 13, 2023	BUY	$65.94 - $99.04 $27.3 Million - $41 Million	414,059 Added 328.27%	540,191 $36.9 Million
Q2 2023 Aug 14, 2023	SELL	$62.68 - $95.05 $1.27 Million - $1.92 Million	-20,242 Reduced 13.83%	126,132 $11.8 Million
Q1 2023 May 15, 2023	BUY	$47.19 - $70.77 $6.91 Million - $10.4 Million	146,374 New	146,374 $9.93 Million
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $6.3 Million - $9.73 Million	197,169 New	197,169 $6.41 Million
Q1 2021 May 14, 2021	SELL	$116.57 - $155.01 $5.17 Million - $6.88 Million	-44,378 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$99.61 - $142.12 $4.42 Million - $6.31 Million	44,378 New	44,378 $5.88 Million

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.